Variable | Poor responders (n = 7) | High responders (n = 14) | Normal responders (n = 14) | P value |
---|---|---|---|---|
Phenotype 1 | 7 | 10 | 7 | – |
Phenotype 2 | 0 | 0 | 0 | – |
Phenotype 3 | 0 | 0 | 0 | – |
Phenotype 4 | 0 | 4 | 7 | – |
Age (years) | 31.43 ± 1.72 | 29.86 ± 4.13 | 30.29 ± 3.31 | 0.546 |
BMI (kg/m2) | 29.07 ± 2.15 | 22.33 ± 3.39a | 23.47 ± 3.76a | < 0.001 |
AFC | 18.64 ± 1.21 | 14.36 ± 1.92ab | 12.57 ± 0.85a | < 0.001 |
Basal FSH level (mIU/ml) | 6.45 ± 1.78 | 6.76 ± 1.79 | 6.57 ± 1.25 | 0.904 |
Basal LH level (mIU/ml) | 4.68 ± 2.08 | 7.17 ± 6.14 | 4.09 ± 1.80 | 0.147 |
Basal estradiol level (pg/ml) | 45.86 ± 19.89 | 45.07 ± 19.93 | 40.57 ± 15.12 | 0.747 |
Basal progesterone level (ng/ml) | 0.64 ± 0.28 | 0.68 ± 0.38 | 0.63 ± 0.60 | 0.965 |
PRL level (ng/ml) | 14.64 ± 6.25 | 20.78 ± 10.92 | 16.92 ± 5.45 | 0.239 |
AMH level (ng/ml) | 10.94 ± 3.80b | 7.50 ± 4.92b | 2.33 ± 2.08 | < 0.001 |
Testosterone level before CPA treatment (ng/ml) | 1.02 ± 0.30 | 0.69 ± 0.30c | 0.57 ± 0.21a | 0.003 |
Testosterone level after CPA treatment (ng/ml) | 0.55 ± 0.14 | 0.61 ± 0.12 | 0.57 ± 0.21 | 0.722 |
No. of previous stimulated cycles | 16 | 2 | 1 | – |
No. of previous canceled cycles | 16 | 0 | 0 | – |